Drug intelligence / Profile preview

standardised 5-grass pollen allergen extract

Development stage
Phase 3
Lead developer
ALK Abelló
Modality
Subcutaneous Immunotherapy → Allergy Immunotherapy → Therapeutic Vaccines → Vaccines & Immunotherapeutics, Sublingual Immunotherapy → Allergy Immunotherapy → Therapeutic Vaccines → Vaccines & Immunotherapeutics
Administration
Sublingual
01

Overview

Standardised 5-grass pollen allergen extract is a form of sublingual immunotherapy (SLIT) used to treat grass pollen-induced allergic rhinoconjunctivitis. It consists of extracts from five common types of grass pollens: Sweet Vernal (Anthoxanthum odoratum), Orchard (Dactylis glomerata), Perennial Rye (Lolium perenne), Timothy (Phleum pratense), and Kentucky Blue Grass (Poa pratensis). [1] Administered as drops under the tongue, the treatment works by gradually exposing the immune system to these allergens, which induces immunological tolerance, reduces the allergic response, and alleviates symptoms. [4, 7] The provided clinical trial context mentions ALK-Abelló as the sponsor, which is notable because ALK's primary grass pollen products (Grastek/Grazax) are based on a single grass, whereas the 5-grass mix is more commonly associated with Stallergenes Greer's products like Oralair (a tablet) and Staloral (drops). [3, 14, 20, 24] A recent Phase III trial by ALK, named RHAPSODY, has specifically evaluated a 5-grass-pollen SLIT drop formulation. [12]

Brand names
Staloral
Other names
5-grass mix SLIT-drops

Beyond the preview

Go deeper on standardised 5-grass pollen allergen extract.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on standardised 5-grass pollen allergen extract.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call